文献速递腹部MR

局部区域治疗后肝细胞癌的MRI评估:综合综述

MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review.
PubMed 文献 · Radiol Imaging Cancer · 2020-01-31

近80%确诊肝细胞癌的肝硬化患者不适合手术切除而接受局部区域治疗,治疗后需影像监测评估疗效并发现肝内其他进展部位。综述回顾肝细胞癌肿瘤反应评估概念、各局部区域治疗方式及治疗后预期影像表现,指出基于放射的治疗(经动脉放射栓塞和立体定向体部放疗)后早期动脉期持续高强化常见且属预期,现有影像治疗反应评估算法须谨慎应用。

要点

  • 放射为基础的治疗后早期动脉期持续高强化常见且属预期,与热消融和经动脉化疗栓塞后的预期表现不同。
  • 现有肝细胞癌影像治疗反应评估算法用于放射为基础的治疗时须谨慎应用。
  • 准确的治疗后影像解读对指导后续管理决策至关重要,放射科医生须了解各治疗方式的预期影像表现。

核心结论

  • 放射科医生须了解每种局部区域治疗的特异性预期影像表现,以准确解读治疗后影像并指导后续管理决策。
  • 现有肝细胞癌影像治疗反应评估算法用于放射为基础的治疗时须谨慎应用,因该治疗后早期动脉期持续高强化常见且属预期。

研究设计与样本

  • 综述文章,回顾肝细胞癌肿瘤反应评估概念、局部区域治疗方式及每种治疗后的预期影像表现。

关键影像表现/征象

  • 放射为基础的治疗(经动脉放射栓塞和立体定向体部放疗)后早期动脉期持续高强化常见且属预期,与热消融和经动脉化疗栓塞后的预期表现不同。

诊断标准与关键数值

  • 现行肝细胞癌影像治疗反应评估算法包括改良实体瘤疗效评价标准分类、欧洲肝脏研究学会标准及肝脏影像报告和数据系统治疗反应算法。

临床应用与阅片要点

  • 解读治疗后影像时须了解各局部区域治疗的预期表现,放射为基础的治疗后早期动脉期持续高强化属预期表现。
  • 应用现有肝细胞癌治疗反应评估算法于放射为基础的治疗时须谨慎。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Nearly 80% of cirrhotic patients diagnosed with hepatocellular carcinoma (HCC) are not eligible for surgical resection and instead undergo local-regional treatment. After therapy for HCC, patients undergo imaging surveillance to assess treatment efficacy and identify potential sites of progressive tumor elsewhere within the liver. Accurate interpretation of posttreatment imaging is essential for guiding further management decisions, and radiologists must understand expected treatment-specific imaging findings for each of the local-regional therapies. Of interest, expected imaging findings seen after radiation-based therapies (transarterial radioembolization and stereotactic body radiation therapy) are different than those seen after thermal ablation and transarterial chemoembolization. Given differences in expected posttreatment imaging findings, the current radiologic treatment response assessment algorithms used for HCC (modified Response Evaluation Criteria in Solid Tumors classification, European Association for the Study of Liver Diseases criteria, and Liver Imaging and Reporting Data System Treatment Response Algorithm) must be applied cautiously for radiation-based therapies in which persistent arterial phase hyperenhancement in the early posttreatment period is common and expected. This article will review the concept of tumor response assessment for HCC, the forms of local-regional therapy for HCC, and the expected posttreatment findings for each form of therapy. Keywords: Abdomen/GI, Liver, MR-Imaging, Treatment Effects, Tumor Response © RSNA, 2020.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Mendiratta-Lala M, Masch WR, Shampain K, et al. MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review. Radiol Imaging Cancer. 2020. PMID: 33778692. doi:10.1148/rycan.2020190024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。